4-100415922-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016242.4(EMCN):c.727G>A(p.Val243Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000202 in 1,585,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00030 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
EMCN
NM_016242.4 missense
NM_016242.4 missense
Scores
3
6
10
Clinical Significance
Conservation
PhyloP100: 4.37
Genes affected
EMCN (HGNC:16041): (endomucin) EMCN is a mucin-like sialoglycoprotein that interferes with the assembly of focal adhesion complexes and inhibits interaction between cells and the extracellular matrix (Kinoshita et al., 2001 [PubMed 11418125]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.033173323).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EMCN | NM_016242.4 | c.727G>A | p.Val243Ile | missense_variant | 10/12 | ENST00000296420.9 | |
EMCN | NM_001159694.2 | c.688G>A | p.Val230Ile | missense_variant | 9/11 | ||
EMCN | XM_011532024.4 | c.727G>A | p.Val243Ile | missense_variant | 10/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EMCN | ENST00000296420.9 | c.727G>A | p.Val243Ile | missense_variant | 10/12 | 1 | NM_016242.4 | P1 | |
EMCN | ENST00000305864.7 | c.478G>A | p.Val160Ile | missense_variant | 7/9 | 1 | |||
EMCN | ENST00000511970.5 | c.688G>A | p.Val230Ile | missense_variant | 9/11 | 2 | |||
EMCN | ENST00000506300.5 | c.197-5567G>A | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000290 AC: 44AN: 151466Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
44
AN:
151466
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000343 AC: 77AN: 224288Hom.: 0 AF XY: 0.000304 AC XY: 37AN XY: 121628
GnomAD3 exomes
AF:
AC:
77
AN:
224288
Hom.:
AF XY:
AC XY:
37
AN XY:
121628
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000191 AC: 274AN: 1433880Hom.: 0 Cov.: 28 AF XY: 0.000216 AC XY: 154AN XY: 712862
GnomAD4 exome
AF:
AC:
274
AN:
1433880
Hom.:
Cov.:
28
AF XY:
AC XY:
154
AN XY:
712862
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000303 AC: 46AN: 151576Hom.: 0 Cov.: 32 AF XY: 0.000257 AC XY: 19AN XY: 74012
GnomAD4 genome
AF:
AC:
46
AN:
151576
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
74012
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The c.727G>A (p.V243I) alteration is located in exon 10 (coding exon 10) of the EMCN gene. This alteration results from a G to A substitution at nucleotide position 727, causing the valine (V) at amino acid position 243 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;T;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
MutationTaster
Benign
D;D;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;T;D
Polyphen
D;D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at